ArticleFrontiers in pharmacology2022

Chidamide-based 3-drug combination regimen reverses molecular relapse post transplantation in AML1-ETO-positive acute myeloid leukemia.

Yang Xi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.